COO Quote, Financials, Valuation and Earnings

OrthoPediatrics has a net margin of 11.54% compared to The Cooper Companies's net margin of -14.51%. The Cooper Companies's return on equity of 5.02% beat OrthoPediatrics's return on equity of -7.63%.

The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 20.69%. On the other hand OrthoPediatrics has an analysts' consensus of $40.17 which suggests that it could grow by 77.93%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.295%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than OrthoPediatrics quarterly revenues of $54.6M. The Cooper Companies's net income of $117.5M is higher than OrthoPediatrics's net income of -$7.9M. Notably, The Cooper Companies's price-to-earnings ratio is 47.59x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.78x versus 2.73x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.

Innovative Eyewear has a net margin of 11.54% compared to The Cooper Companies's net margin of -678.5%. The Cooper Companies's return on equity of 5.02% beat Innovative Eyewear's return on equity of -113.55%.

The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 20.69%. On the other hand Innovative Eyewear has an analysts' consensus of -- which suggests that it could grow by 144.76%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than Innovative Eyewear quarterly revenues of $253.6K. The Cooper Companies's net income of $117.5M is higher than Innovative Eyewear's net income of -$1.7M. Notably, The Cooper Companies's price-to-earnings ratio is 47.59x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.78x versus 3.73x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.

NexGel has a net margin of 11.54% compared to The Cooper Companies's net margin of -23.57%. The Cooper Companies's return on equity of 5.02% beat NexGel's return on equity of -67.5%.

The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 20.69%. On the other hand NexGel has an analysts' consensus of -- which suggests that it could grow by 26.58%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than NexGel quarterly revenues of $2.9M. The Cooper Companies's net income of $117.5M is higher than NexGel's net income of -$693K. Notably, The Cooper Companies's price-to-earnings ratio is 47.59x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.78x versus 4.32x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.

Staar Surgical has a net margin of 11.54% compared to The Cooper Companies's net margin of 11.27%. The Cooper Companies's return on equity of 5.02% beat Staar Surgical's return on equity of 5.46%.

The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 20.69%. On the other hand Staar Surgical has an analysts' consensus of $41.89 which suggests that it could grow by 67.74%. Given that Staar Surgical has higher upside potential than The Cooper Companies, analysts believe Staar Surgical is more attractive than The Cooper Companies.

The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Staar Surgical has a beta of 0.587, suggesting its less volatile than the S&P 500 by 41.304%.

The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.

The Cooper Companies quarterly revenues are $1B, which are larger than Staar Surgical quarterly revenues of $88.6M. The Cooper Companies's net income of $117.5M is higher than Staar Surgical's net income of $10M. Notably, The Cooper Companies's price-to-earnings ratio is 47.59x while Staar Surgical's PE ratio is 56.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.78x versus 3.62x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.